BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//talks.cam.ac.uk//v3//EN
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:19700329T010000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:19701025T020000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
CATEGORIES:Computational and Systems Biology
SUMMARY:To be confirmed - Daniel Crowther
DTSTART;TZID=Europe/London:20060215T140000
DTEND;TZID=Europe/London:20060215T150000
UID:TALK4780AThttp://talks.cam.ac.uk
URL:http://talks.cam.ac.uk/talk/index/4780
DESCRIPTION:GlaxoSmithKline is one of the worlds leading pharm
 aceutical companies.\nIn this talk I will aim to i
 ntroduce the drug development process and\nhighlig
 ht some of the ways in which bioinformatics is app
 lied to the\ndrug development process in GSK. The 
 talk will focus on several key\nareas of impact\, 
 starting with target identification and validation
 \nincluding the application of structural analysis
  to protein\nengineering\, describe the role of bi
 oinformatics in handing human\nvariation and finis
 hing with at role bioinformatics plays in the\ndis
 covery and application of biomarkers.\n
LOCATION:MR5\, DAMTP
CONTACT:Stephen Eglen
END:VEVENT
END:VCALENDAR